Showing 1 - 8 results of 8 for search 'Lixin Fang', query time: 0.04s Refine Results
  1. 1
    The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment

    The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment by Lixin Fang, Lixin Fang, Huoxiang Zhou, Huoxiang Zhou, Long Cheng, Yiyi Wang, Fei Liu, Suping Wang

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Global–local multi-stage temporal convolutional network for cataract surgery phase recognition

    Global–local multi-stage temporal convolutional network for cataract surgery phase recognition by Lixin Fang, Lei Mou, Yuanyuan Gu, Yan Hu, Bang Chen, Xu Chen, Yang Wang, Jiang Liu, Yitian Zhao

    Published 2022-11-01
    Get full text
    Article
  3. 3
    A novel selective PPARα modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms.

    A novel selective PPARα modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms. by Hiroshi Kawanishi, Koji Ohashi, Hayato Ogawa, Naoya Otaka, Tomonobu Takikawa, Lixin Fang, Yuta Ozaki, Mikito Takefuji, Toyoaki Murohara, Noriyuki Ouchi

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Silica nanoparticles containing nano-silver and chlorhexidine to suppress Porphyromonas gingivalis biofilm and modulate multispecies biofilms toward healthy tendency

    Silica nanoparticles containing nano-silver and chlorhexidine to suppress Porphyromonas gingivalis biofilm and modulate multispecies biofilms toward healthy tendency by Lixin Fang, Yishuang Zhang, Long Cheng, Hao Zheng, Yiyi Wang, Lu Qin, Yingchun Cai, Lei Cheng, Wen Zhou, Fei Liu, Suping Wang

    Published 2024-12-01
    Get full text
    Article
  5. 5
    Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial‐mesenchymal transition and inflammatory response

    Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial‐mesenchymal transition and inflammatory response by Lixin Fang, Koji Ohashi, Hayato Ogawa, Naoya Otaka, Hiroshi Kawanishi, Tomonobu Takikawa, Yuta Ozaki, Kunihiko Takahara, Minako Tatsumi, Mikito Takefuji, Toyoaki Murohara, Noriyuki Ouchi

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction.

    Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction. by Tomonobu Takikawa, Koji Ohashi, Hayato Ogawa, Naoya Otaka, Hiroshi Kawanishi, Lixin Fang, Yuta Ozaki, Shunsuke Eguchi, Minako Tatsumi, Mikito Takefuji, Toyoaki Murohara, Noriyuki Ouchi

    Published 2020-01-01
    Get full text
    Article
  7. 7
    Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation

    Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation by Lixin Fang, Koji Ohashi, Satoko Hayakawa, Hayato Ogawa, Naoya Otaka, Hiroshi Kawanishi, Tomonobu Takikawa, Yuta Ozaki, Kunihiko Takahara, Minako Tatsumi, Mikito Takefuji, Yuuki Shimizu, Yasuko K. Bando, Yuya Fujishima, Norikazu Maeda, Iichiro Shimomura, Toyoaki Murohara, Noriyuki Ouchi

    Published 2023-05-01
    Get full text
    Article
  8. 8
    Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway

    Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway by Yuta Ozaki, Koji Ohashi, Naoya Otaka, Hiroshi Kawanishi, Tomonobu Takikawa, Lixin Fang, Kunihiko Takahara, Minako Tatsumi, Sohta Ishihama, Mikito Takefuji, Katsuhiro Kato, Yuuki Shimizu, Yasuko K. Bando, Aiko Inoue, Masafumi Kuzuya, Shinji Miura, Toyoaki Murohara, Noriyuki Ouchi

    Published 2023-08-01
    Get full text
    Article

Search Tools: